Fengmin Shao

1.5k total citations
52 papers, 749 citations indexed

About

Fengmin Shao is a scholar working on Molecular Biology, Cancer Research and Nephrology. According to data from OpenAlex, Fengmin Shao has authored 52 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Nephrology. Recurrent topics in Fengmin Shao's work include Acute Kidney Injury Research (5 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (4 papers). Fengmin Shao is often cited by papers focused on Acute Kidney Injury Research (5 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (4 papers). Fengmin Shao collaborates with scholars based in China, United States and Australia. Fengmin Shao's co-authors include Huixia Cao, Xu Ma, Lei Yan, Guang‐Hui Liu, Lei Yan, Xiaojing Jiao, Yue Gu, Lianzhong Zhang, Jianqin Gu and Bing Liu and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Fengmin Shao

42 papers receiving 740 citations

Peers

Fengmin Shao
Maria Ida Amabile Italy
Simona Mihai Romania
Lan Xiao China
Chengyun Xu China
Miao Lin China
Mohsen Honarpisheh Germany
Jun Morinaga Japan
Hirofumi Hamano Japan
Pablo Cannata Spain
Maria Ida Amabile Italy
Fengmin Shao
Citations per year, relative to Fengmin Shao Fengmin Shao (= 1×) peers Maria Ida Amabile

Countries citing papers authored by Fengmin Shao

Since Specialization
Citations

This map shows the geographic impact of Fengmin Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengmin Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengmin Shao more than expected).

Fields of papers citing papers by Fengmin Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengmin Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengmin Shao. The network helps show where Fengmin Shao may publish in the future.

Co-authorship network of co-authors of Fengmin Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Fengmin Shao. A scholar is included among the top collaborators of Fengmin Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengmin Shao. Fengmin Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ruijia, Wenting Luo, Shiyu Liu, et al.. (2025). Enhancing fruit quality through unraveling the molecular and physiological basis and preventing cracking in jujube (Ziziphus jujuba Mill.). Postharvest Biology and Technology. 223. 113417–113417.
2.
3.
Miao, Yandong, Lei Yan, Huixia Cao, Xiaojing Jiao, & Fengmin Shao. (2025). The Mitochondrial Metabolism Gene ECH1 Was Identified as a Novel Biomarker for Diabetic Nephropathy: Using Bioinformatics Analysis and Experimental Confirmation. Diabetes Metabolic Syndrome and Obesity. Volume 18. 1087–1098. 1 indexed citations
4.
Yin, Jianjian, Qi Chang, Tao Wang, et al.. (2025). The N1‐methyladenosine methyltransferase TRMT61A promotes bladder cancer progression and is targetable by small molecule compounds. Clinical and Translational Medicine. 15(1). e70137–e70137.
5.
Zhao, Yunjie, Fengmin Shao, Lin Li, et al.. (2025). Evodiamine inhibits NLRP3 inflammasome-mediated microglial pyroptosis and promotes remyelination via SLC2A4-regulated autophagy. Phytomedicine. 143. 156866–156866.
6.
Zhang, Lina, Yanfang Lu, Yanliang Wang, et al.. (2025). Cellular hierarchy framework based on single-cell and bulk RNA sequencing reveals fatty acid metabolic biomarker MYDGF as a therapeutic target for ccRCC. Frontiers in Immunology. 16. 1615601–1615601.
7.
8.
Zhang, Lina, Yanliang Wang, Jing Tan, et al.. (2024). Receptor-interacting protein kinase 1 confers autophagic promotion of gasdermin E-mediated pyroptosis in aristolochic acid-induced acute kidney injury. Ecotoxicology and Environmental Safety. 284. 116944–116944. 1 indexed citations
9.
Sun, Xiaoya, Rick F. Thorne, Xu Dong Zhang, et al.. (2023). NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells. Journal of Translational Medicine. 21(1). 401–401. 8 indexed citations
10.
Yan, Lei, et al.. (2023). Study on the correlation between mineral bone metabolism and CRP in patients with SHPT during perioperative period. Immunity Inflammation and Disease. 11(4). e828–e828. 3 indexed citations
11.
Shang, Junkui, Wei Li, Huiwen Zhang, et al.. (2023). C-kit controls blood-brain barrier permeability by regulating caveolae-mediated transcytosis after chronic cerebral hypoperfusion. Biomedicine & Pharmacotherapy. 170. 115778–115778. 6 indexed citations
12.
Wu, Xiaoqiang, Guanghui Cao, Zhiwei Wang, et al.. (2022). Antibiotic ampicillin induces immune tolerance in renal transplantation by regulating the proportion of intestinal flora in mice. Frontiers in Cellular and Infection Microbiology. 12. 1048076–1048076. 3 indexed citations
13.
Huang, Shenzhen, Lijuan Chen, Xiaoyan Dong, et al.. (2021). Research Progress of DCLK1 Inhibitors as Cancer Therapeutics. Current Medicinal Chemistry. 29(13). 2261–2273. 7 indexed citations
14.
Yang, Zhong‐Nan, Lei Yan, Huixia Cao, et al.. (2021). Erythropoietin Protects against Diffuse Alveolar Hemorrhage in Mice by Regulating Macrophage Polarization through the EPOR/JAK2/STAT3 Axis. The Journal of Immunology. 206(8). 1752–1764. 9 indexed citations
15.
Niu, Xiaona, Jie Shi, Weiya Li, et al.. (2021). Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia. Frontiers in Oncology. 11. 763232–763232. 14 indexed citations
16.
Wu, Yaping, Tao Feng, Tianyi Xu, et al.. (2021). Whole-Body Parametric Imaging of 18F-FDG PET Using uEXPLORER with Reduced Scanning Time. Journal of Nuclear Medicine. 63(4). 622–628. 42 indexed citations
17.
Gu, Jianqin, et al.. (2020). Application and Preliminary Outcomes of Remote Diagnosis and Treatment During the COVID-19 Outbreak: Retrospective Cohort Study. JMIR mhealth and uhealth. 8(7). e19417–e19417. 48 indexed citations
18.
Zheng, Yan, Yuan Ma, Huixia Cao, et al.. (2020). Identification of fenoldopam as a novel LSD1 inhibitor to abrogate the proliferation of renal cell carcinoma using drug repurposing strategy. Bioorganic Chemistry. 108. 104561–104561. 9 indexed citations
19.
Zhang, Hong, et al.. (2018). EPO Derivative ARA290 Attenuates Early Renal Allograft Injury in Rats by Targeting NF-κB Pathway. Transplantation Proceedings. 50(5). 1575–1582. 10 indexed citations
20.
Fang, Qin, Fan Yu, Ying Tan, et al.. (2008). Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis. Nephrology Dialysis Transplantation. 24(1). 172–178. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Ida Amabile Breakdown of academic impact, for papers by Simona Mihai Breakdown of academic impact, for papers by Lan Xiao Breakdown of academic impact, for papers by Chengyun Xu Breakdown of academic impact, for papers by Miao Lin Breakdown of academic impact, for papers by Mohsen Honarpisheh Breakdown of academic impact, for papers by Jun Morinaga Breakdown of academic impact, for papers by Hirofumi Hamano Breakdown of academic impact, for papers by Pablo Cannata
Rankless by CCL
2026